RIMEGEPANT (Vydura®)
Clinical Indication
For treating acute migraine
Comments
As per NICE TA919
Subject to a confirmed diagnosis of migraine by specialist or if patient cannot tolerate triptans.
Date of classification
December 2023
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.